Welcome to LookChem.com Sign In|Join Free
  • or
N-ACETYL-2-METHYL-BUTYNYLAMINE, a chemical compound with the molecular formula C6H11NO, belongs to the alkylamines family and is derived from butynylamine. It is known for its reactivity in organic synthesis, its ability to form salts with acids, and its antimicrobial properties, which make it a versatile compound for various applications.

21604-47-7

Post Buying Request

21604-47-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21604-47-7 Usage

Uses

Used in Organic Synthesis:
N-ACETYL-2-METHYL-BUTYNYLAMINE is used as a reagent in organic synthesis for its ability to react with acids to form salts, facilitating the synthesis of various organic compounds.
Used in Pharmaceutical and Medical Applications:
Due to its antimicrobial properties, N-ACETYL-2-METHYL-BUTYNYLAMINE is used as an active ingredient in pharmaceutical formulations and medical treatments to combat infections caused by various microorganisms.
Used in Research for Disease Treatment:
N-ACETYL-2-METHYL-BUTYNYLAMINE is used as a subject of research for its potential therapeutic benefits in the treatment of various diseases and disorders. Further studies are needed to fully understand its potential and optimize its use in medical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 21604-47-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,6,0 and 4 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 21604-47:
(7*2)+(6*1)+(5*6)+(4*0)+(3*4)+(2*4)+(1*7)=77
77 % 10 = 7
So 21604-47-7 is a valid CAS Registry Number.

21604-47-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name N-ACETYL-2-METHYL-BUTYNYLAMINE

1.2 Other means of identification

Product number -
Other names N-(1,1-dimethylpropargyl)acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21604-47-7 SDS

21604-47-7Relevant academic research and scientific papers

Regioselective Synthesis of Multifunctional Allylic Amines; Access to Ambiphilic Aziridine Scaffolds

McLaughlin, Mark G.,Roberts, Dean D.

supporting information, p. 4463 - 4467 (2021/06/28)

We describe, for the first time, a highly regioselective hydrosilylation of propargylic amines. The reaction utilizes a PtCl2/XantPhos catalyst system to deliver hydrosilanes across the alkyne to afford multifunctional allylic amines in high yields. The reaction is tolerant to a wide variety of functional groups and provides high value intermediates with two distinct functional handles. The synthetic applicability of the reaction has been shown through the synthesis of diverse ambiphilic aziridines.

THERAPEUTIC COMPOUNDS AND USES THEREOF

-

Page/Page column 91, (2016/08/23)

The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.

CuI-catalyzed cycloisomerization of propargyl amides

Alhalib, Ali,Moran, Wesley J.

, p. 795 - 800 (2014/01/23)

The synthesis of substituted dihydrooxazoles by the CuI-catalyzed cycloisomerization of terminal propargyl amides is reported. The reaction has been shown to have good substrate scope and experiments to delineate the mechanism have been performed. Substrates containing a benzylic methylene were oxidized to the ketone under the reaction conditions.

Cyclization-carbonylation-cyclization coupling reactions of propargyl acetates and amides with palladium(II)-bisoxazoline catalysts

Yasuhara, Sumie,Sasa, Makiko,Kusakabe, Taichi,Takayama, Hiroyuki,Kimura, Masayuki,Mochida, Tomoyuki,Kato, Keisuke

supporting information; experimental part, p. 3912 - 3915 (2011/06/20)

Clever boxing: A cyclization-carbonylation-cyclization-coupling reaction of propargyl acetates 1 or amides 2 in the presence of a palladium(II)- bisoxazoline (box) catalyst afforded symmetrical ketones of types 3 and 4, respectively, containing two heterocyclic groups in moderate to excellent yields (see scheme; tfa=trifluoroacetate). Compounds 3 were converted into ketones containing two 3(2H)-furanone rings.

The synthesis and structure-activity relationship studies of selective acetyl-CoA carboxylase inhibitors containing 4-(thiazol-5-yl)but-3-yn-2-amino motif: Polar region modifications

Xu, Xiangdong,Weitzberg, Moshe,Keyes, Robert F.,Li, Qun,Wang, Rongqi,Wang, Xiaojun,Zhang, Xiaolin,Frevert, Ernst U.,Camp, Heidi S.,Beutel, Bruce A.,Sham, Hing L.,Gu, Yu Gui

, p. 1803 - 1807 (2007/10/03)

The structure-activity relationship study focused on the polar region of the HTS hit A-80040 (1) producing several series of potent and selective ACC2 inhibitors. The SAR suggests a compact lipophilic pocket that does not tolerate polar and ionic groups.

Substituted bicyclic derivatives useful as anticancer agents

-

, (2008/06/13)

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts and solvates thereof, wherein A, X, R1, R3and R4are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals with administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 21604-47-7